Notably, CTNNB1 is a well-known oncogene that is also the second most frequently mutated gene after TP53 in hepatocellular carcinoma (HCC) (26% versus 30.8% of TCGA-liver HCC (LIHC) tumour samples). This evidence concerns the gene CTNNB1 and neoplasm.